The Use of Liposomal Bupivacaine in TAP Blocks for Women Undergoing Cesarean Section

Trial Profile

The Use of Liposomal Bupivacaine in TAP Blocks for Women Undergoing Cesarean Section

Not yet recruiting
Phase of Trial: Phase II/III

Latest Information Update: 11 Jun 2018

At a glance

  • Drugs Bupivacaine (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Jun 2018 Planned End Date changed from 1 Aug 2018 to 1 Oct 2019.
    • 05 Jun 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Oct 2019.
    • 05 Jun 2018 Planned initiation date changed from 1 Apr 2018 to 1 Oct 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top